CGON (CG Oncology) Other Current Liabilities: $4.71 Mil (As of Mar. 2026)


CGON CG Oncology Inc CGON
12 GF Score
Price $75.24
! 5 Warning Signs
View Full Analysis

What is CG Oncology Other Current Liabilities?

CG Oncology CGON +2.58% 12 Other Current Liabilities is $4.71 Mil as of Mar. 2026. GuruFocus rates CGON with a GF Score™ of 12/100. The stock has 5 warning signs investors should review.

CG Oncology's other current liabilities for the quarter that ended in Mar. 2026 was $4.71 Mil.

CG Oncology's quarterly other current liabilities increased from Sep. 2025 ($6.63 Mil) to Dec. 2025 ($9.02 Mil) but then declined from Dec. 2025 ($9.02 Mil) to Mar. 2026 ($4.71 Mil).

CG Oncology's annual other current liabilities increased from Dec. 2023 ($3.27 Mil) to Dec. 2024 ($6.23 Mil) and increased from Dec. 2024 ($6.23 Mil) to Dec. 2025 ($9.02 Mil).

CG Oncology Other Current Liabilities Related Terms

CG Oncology Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for CG Oncology's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CG Oncology Other Current Liabilities Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
1.13 2.01 3.27 6.23 9.02

CG Oncology Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.60 4.80 6.63 9.02 4.71
CGON
12GF Score
CG Oncology Inc CGON
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CG Oncology Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $4.71 Mil mean?
CG Oncology (CGON) has a Other Current Liabilities of $4.71 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on CG Oncology.
Is CG Oncology's Other Current Liabilities too high?
CG Oncology's current Other Current Liabilities is $4.71 Mil. Overall, CG Oncology has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CG Oncology's Other Current Liabilities compare to COGT and SRRK?
CG Oncology's Other Current Liabilities of $4.71 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on CG Oncology. CG Oncology's current Other Current Liabilities is $4.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CG Oncology stock overvalued right now?
CG Oncology (CGON) has a current Other Current Liabilities of $4.71 Mil. The current Other Current Liabilities is $4.71 Mil. CG Oncology's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For CG Oncology (CGON), the current Other Current Liabilities is $4.71 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CG Oncology Business Description

Address 400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
12GF Score

Get the complete analysis for CGON

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$75.24
Price